@techinasia.com 9 months ago
In 50 Words: Genesis MedTech plans Hong Kong IPO, may raise up to $500m
@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com 5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs